AMPRIVA
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Apr 2025)
What this means for you
This application is over — abandoned 07 Apr 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98177420
- Mark type
- Stylized text
- Filed
- 13 Sept 2023
- Published for opposition
- 09 Jul 2024
- Abandoned
- 07 Apr 2025
- Attorney of record
- Joe Guagliardo
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multiple sclerosis and other neurological disorders or conditions
Owner
- MERZ PHARMACEUTICALS, LLC, RALEIGH, NC, US
- Acorda Therapeutics, Inc., Pearl River, NY, US
- Acorda Therapeutics, Inc., Pearl River, NY, US
Prosecution history
- 07 Apr 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Apr 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 May 2024 — EXAMINER'S AMENDMENT ENTERED
- 23 May 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 May 2024 — EXAMINERS AMENDMENT E-MAILED
- 23 May 2024 — EXAMINERS AMENDMENT -WRITTEN
- 23 May 2024 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 21 May 2024 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 08 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER